Abstract: From the global enddiastolic volume GEDV and the global ejection fraction GEF the patient monitor (4) determines a corrected global enddiastolic volume cGEDV according to cGEDV=GEDV/f(GEF) which is used as a novel paramater for volume responsiveness of the patient (3). In the above formula, f(GEF) is a correction function depending on global ejection fraction GEF. Further, from the right ventricular enddiastolic volume RVEDV and the right ventricular ejection fraction RVEF the patient monitor (4) determines a corrected right ventricular enddiastolic volume cRVEDV according to cRVEDV=RVEDV/f(RVEF) which is used as another novel paramater for volume responsiveness of the patient (3). In the above formula, f(RVEF) is a correction function depending on right ventricular ejection fraction RVEF.

Abstract: The present invention relates to a process and devices for determining the instant of injection and the duration of injection in thermodilution measurements in which an injectate fluid at a temperature deviating from the temperature of the blood of a patient is injected at a specific injection site into a blood vessel of the patient and the temperature of the blood is measured at a measuring site downstream of the injection site, the injectate fluid being used at approximately room temperature and, before entry into the blood vessel, passed by a temperature sensor which, before the measurement, has a temperature deviating from room temperature, the temperature determined by the temperature sensor being sensed continuously, the instant of the beginning of injection being determined from a change occurring in the sensed temperature and the instant of the end of injection being determined from a subsequently occurring change in direction of the temperature profile.